All stock lists
Glass House Brands Inc. (New York Stock Exchange:GLAS)
US · Delayed Price · Currency is USD
Healthcare · Drug Manufacturers - Specialty & Generic
2.14+0.00 (+0.00%)
Insider Score
––Not scored
GLAS Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
GLAS analyst forecast
GLAS analyst consensus
Moderate Buy1 ratings
Buy 1 Hold 0 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
GLAS 12-month price target
No published price targets in the last 12 months.
Best analysts covering GLAS
No firm covering GLAS has enough calls with a finished 1Y holding period to rank yet.
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
GLAS analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| — | Lake Street | Buy | — | — | Reiterated | 2026-10-20 |
GLAS earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-03-24 | -0.19 | -0.20 | $38.8M | $38.9M |
| 2026-05-13 | -0.17 | -0.20 | $40.1M | $40.5M |
| 2026-08-14 | -0.08 | -0.08 | $54.4M | $47.0M |
| 2026-11-11 | -0.13 | 0.00 | $56.8M | $0 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.